Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double- blind, placebo-controlled trial Milagritos D Tapia, MD, Prof Samba O Sow, MD, Kirsten E Lyke, MD, Fadima Cheick Haidara, MD, Fatoumata Diallo, MD, Moussa Doumbia, MD, Awa Traore, PharmD, Flanon Coulibaly, MD, Mamoudou Kodio, PharmD, Uma Onwuchekwa, BS, Prof Marcelo B Sztein, MD, Rezwanul Wahid, PhD, Prof James D Campbell, MD, Marie-Paule Kieny, PhD, Vasee Moorthy, DPhil, Egeruan B Imoukhuede, MBBS, Tommy Rampling, MRCP, Francois Roman, MD, Iris De Ryck, MD, Abbie R Bellamy, PhD, Len Dally, MS, Olivier Tshiani Mbaya, MD, Aurélie Ploquin, PhD, Yan Zhou, PhD, Daphne A Stanley, MS, Robert Bailer, PhD, Richard A Koup, MD, Mario Roederer, PhD, Julie Ledgerwood, DO, Prof Adrian V S Hill, DM, W Ripley Ballou, MD, Nancy Sullivan, PhD, Barney Graham, MD, Prof Myron M Levine, MD The Lancet Infectious Diseases Volume 16, Issue 1, Pages (January 2016) DOI: /S (15)00362-X Copyright © 2016 Tapia et al. Open Access article distributed under the terms of CC BY Terms and Conditions Terms and Conditions

Figure 1 The Lancet Infectious Diseases , 31-42DOI: ( /S (15)00362-X) Copyright © 2016 Tapia et al. Open Access article distributed under the terms of CC BY Terms and Conditions Terms and Conditions

Figure 2 The Lancet Infectious Diseases , 31-42DOI: ( /S (15)00362-X) Copyright © 2016 Tapia et al. Open Access article distributed under the terms of CC BY Terms and Conditions Terms and Conditions